Navigating prognostic communication when children with poor-prognosis cancer experience prolonged disease stability

被引:8
|
作者
Porter, Amy S. [1 ]
Chow, Emma [1 ,2 ]
Woods, Cameka [1 ]
Lemmon, Monica E. [3 ]
Baker, Justin N. [1 ]
Mack, Jennifer W. [4 ,5 ]
Kaye, Erica C. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA
[2] Rhodes Coll, Memphis, TN 38112 USA
[3] Duke Childrens Hlth Ctr, Dept Pediat, Durham, NC USA
[4] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Dept Pediat, Boston, MA USA
关键词
cancer; communication; pediatric; prognosis; uncertainty; PARENTS; DISCUSSIONS; PREDICTIONS; PHYSICIANS; SURVIVAL; IMPACT;
D O I
10.1002/pbc.29920
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Most pediatric patients and families want clear prognostic information across the illness course. Yet when children with poor-prognosis cancer experience prolonged disease stability, uncertainty can make communication particularly challenging. In this study, we aimed to (i) assess how frequently oncologists communicate about prognosis when high-risk cancer does not progress, and (ii) describe prognostic communication patterns in the context of disease stability. Patients and methods In this prospective, longitudinal, mixed-methods study, we audio-recorded serial disease re-evaluation conversations between children with poor-prognosis cancer, their families, and their primary oncologists. For this secondary analysis, we conducted content analysis across serial conversations among 16 patient-parent-oncologist triads for whom the patient's disease remained stable over the 24-month study period. Results Prognostic communication was absent in >50% of recorded conversations. Overall, it comprised only 4% of dialog time, nearly 90% of which was dialog about prognostic uncertainty; discussion of curability occurred infrequently. Three distinct patterns for prognostic communication emerged: (a) "Don't know" statements, avoiding or deferring prognostication; (b) "Worry" statements, preparing families for possible future disease progression; and (c) relief-caveat statements, celebrating disease stability while balancing positivity with caution. Conclusions Oncologists seldom talked about prognosis with high-risk patients during periods of disease stability; yet when they did, they used thoughtful and effective strategies to prepare families for possible future disease progression. Further research is needed to better understand if, how, and when patients and families with stable disease who are high risk for future disease progression prefer to receive information about prognosis.
引用
收藏
页数:11
相关论文
共 22 条
  • [1] High-dose chemotherapy in children and adolescents with poor-prognosis Hodgkin's disease
    Kabickova, E
    Sumerauer, D
    Kobylka, P
    Cumlivska, E
    Vicha, A
    Valkova, J
    Kodet, R
    Koutecky, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S243 - S244
  • [2] IMPROVED OUTCOME FOR POOR-PROGNOSIS METASTATIC GERM CELL CANCER: A SINGLE CENTER EXPERIENCE IN JAPAN
    Yamada, Shigeyuki
    Saito, Hideo
    Kaiho, Yasuhiro
    Ito, Akihiro
    Ishidoya, Shigeto
    Arai, Yoichi
    JOURNAL OF UROLOGY, 2010, 183 (04): : E328 - E329
  • [3] Experience with Prognosis Communication in Parents of Children Having Advanced Cancer
    Ghoshal, A.
    Muckaden, M. A.
    Garg, C.
    Iyengar, J.
    Ganpathy, K. V.
    Damani, A.
    Deodhar, J.
    Vora, T.
    Chinnaswamy, G.
    INDIAN JOURNAL OF PEDIATRICS, 2022, 89 (09): : 924 - 924
  • [4] Experience with Prognosis Communication in Parents of Children Having Advanced Cancer
    A. Ghoshal
    MA Muckaden
    C. Garg
    J. Iyengar
    K. V. Ganpathy
    A. Damani
    J. Deodhar
    T. Vora
    G. Chinnaswamy
    Indian Journal of Pediatrics, 2022, 89 : 924 - 924
  • [5] Feasibility and safety of peripheral blood stem cell collection in children with poor-prognosis solid tumors: A single center experience
    Dolgopolov, I
    Yankelevich, M
    Andreeva, L
    Mscheidze, D
    Ijoguine, D
    Siegel, S
    Mentkevich, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (04) : 291 - 298
  • [6] POOR-PROGNOSIS METASTATIC GESTATIONAL TROPHOBLASTIC DISEASE - EXPERIENCE WITH MODERATE DOSE METHOTREXATE PLUS FOLINIC ACID RESCUE AS INITIAL THERAPY
    GERULATH, AH
    DEMBO, AJ
    RIDER, WD
    AITKEN, S
    QUIRT, IC
    OSBORNE, R
    BLACKSTEIN, R
    GYNECOLOGIC ONCOLOGY, 1986, 23 (02) : 263 - 263
  • [7] Treatment outcome of patients with intermediate- and poor-prognosis metastatic testicular cancer in the 2000s: A multicenter experience in Japan
    Kojima, Takahiro
    Kawai, Koji
    Tsuchiya, Kunihiko
    Abe, Takashige
    Shinohara, Nobuo
    Tanaka, Toshiaki
    Masumori, Naoya
    Yamada, Shigeyuki
    Arai, Yoichi
    Narita, Shintaro
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    Nishiyama, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [8] Impact of high-dose cytosine arabinoside in poor-prognosis acute lymphoblastic leukemia: Cancer Institute experience, Chennai, India
    Sagar, TG
    Ganapathy, S
    Devarajan, S
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1998, 15 (04) : 317 - 323
  • [9] Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling
    Kollmannsberger, C
    Nichols, C
    Meisner, C
    Mayer, F
    Kanz, L
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 2000, 11 (09) : 1115 - 1120
  • [10] BOMP EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ cell tumors:: The Spanish germ cell cancer group experience (GG)
    Germà, JR
    del Muro, XG
    Tabernero, JM
    Sánchez, M
    Aparicio, J
    Alba, E
    Barnadas, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S82 - S82